Dover Corporation director Marc A. Howze added 970 shares to his personal stake on November 16, a grant valued at roughly $200K that lifts his direct holdings to 3,004 shares.
The transaction, disclosed in a Form 4 filed with the SEC on November 18, was coded as an award rather than an open-market purchase, meaning Howze did not write a check for the stock. Stock Titan reported the per-share price at $206.12, matching the valuation used for the grant.
Kalkine.com noted the filing did not indicate the transaction was made under a Rule 10b5-1 trading plan, the mechanism insiders often use to schedule sales or purchases in advance and shield themselves from accusations of timing the market.
Grants like this are standard fare for public-company boards. Directors typically receive an annual retainer split between cash and restricted stock units that vest over time, aligning their incentives with long-term shareholders without requiring them to deploy personal capital.
The 970 shares represent about a 48 percent increase in Howze’s direct position, but given Dover’s market capitalization, the move is too small to indicate a change in corporate strategy or insider sentiment.
What the filing does confirm is that Howze, who lists a Downers Grove, Illinois address on the form, continues to hold his entire Dover stake directly — no family trusts, no LLCs, no derivative hedges. Table II of the Form 4 shows zero derivative securities beneficially owned after the transaction.
John C. Nelson signed the filing as attorney-in-fact for Howze, a routine delegation that allows a corporate secretary or outside counsel to meet the SEC’s two-business-day reporting deadline. The form was filed on November 18, two calendar days after the grant date, comfortably within the window required by Section 16 of the Securities Exchange Act.